tradingkey.logo
tradingkey.logo
Buscar

Neuropace Inc

NPCE
Añadir a la lista de seguimiento
16.140USD
+0.370+2.35%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
541.90MCap. mercado
PérdidaP/E TTM

Más Datos de Neuropace Inc Compañía

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.

Información de Neuropace Inc

Símbolo de cotizaciónNPCE
Nombre de la empresaNeuropace Inc
Fecha de salida a bolsaApr 22, 2021
Director ejecutivoBecker (Joel D)
Número de empleados184
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 22
Dirección455 N. Bernardo Avenue
CiudadMOUNTAIN VIEW
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94043
Teléfono16502372700
Sitio Webhttps://www.neuropace.com/
Símbolo de cotizaciónNPCE
Fecha de salida a bolsaApr 22, 2021
Director ejecutivoBecker (Joel D)

Ejecutivos de Neuropace Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
599.53K
+0.73%
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
366.48K
+89.08%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
110.42K
-0.30%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
68.67K
+24.49%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
23.04K
+16.84%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
18.54K
+19.85%
Ms. Renee Ryan
Ms. Renee Ryan
Independent Director
Independent Director
--
--
Ms. Lisa Andrade
Ms. Lisa Andrade
Independent Director
Independent Director
--
--
Mr. Joel D. Becker
Mr. Joel D. Becker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
599.53K
+0.73%
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
366.48K
+89.08%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
110.42K
-0.30%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
68.67K
+24.49%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
23.04K
+16.84%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
18.54K
+19.85%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Neuropace Inc?

Los cinco principales accionistas de Neuropace Inc son: Mr. Frank M. Fischer

¿Cuántas instituciones poseen acciones de Neuropace Inc (NPCE)?

A fecha de 2026Q1, 223 instituciones poseen acciones de Neuropace Inc, con un valor de mercado combinado de aproximadamente 33.54M, lo que representa el 99.26% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -4152379.00.